1063 Topically Applied NanoFlares to Measure Gene Expression in Vivo: Proof-of-concept
A. S. Paller,D. Yeo,C. Wiraja,C. Mirkin,C. Xu
DOI: https://doi.org/10.1016/j.jid.2018.03.1076
IF: 7.59
2018-01-01
Journal of Investigative Dermatology
Abstract:Spherical nucleic acids (SNAs) are topical agents that penetrate human skin to knock down genes via antisense and siRNA pathways. NanoFlares, SNAs that release sequence-specific fluorescence when binding to intracellular mRNA targets, measure mRNA levels in live cells. We hypothesized that NanoFlares could be topically applied to measure gene expression in vivo. As proof-of-concept, we detected connective tissue growth factor (CTGF), known to be increased in hypertrophic scars and keloids. Using fibroblasts from normal skin, keloids, hypertrophic scars and peri-scar tissue, we found that: a) NanoFlares are specific; b) expression measured by NanoFlares mirrors that by RT-PCR; and c) NanoFlares can detect expression changes after treatment with inducers (e.g., TGF-β) or inhibitors (e.g., RepSox, rapamycin, anti-TGF-β siRNA). To test in vivo application, we confirmed by IVIS imaging that GAPDH NanoFlares in Aquaphor penetrate hairless mouse and human abdominoplasty skin (8x more expression than scrambled). CTGF NanoFlares, but not controls, co-localized with labelled fibroblasts in 3-D scar models and quantification of signal showed strong correlation (r=0.95). Treatment of scar fibroblasts with RepSox reduced CTGF NanoFlare detection to that of normal fibroblasts. Finally, NanoFlares detected 2.25-fold more CTGF expression in the rabbit ear hypertrophic scar model vs unwounded skin using IVIS imaging and normalizing the Cy5 fluorescent signal to GAPDH/cell number. These data suggest that NanoFlares can be topically applied to measure changes in gene expression, raising the possibility of adaptation to noninvasively diagnose disease based on altered gene expression or mutation, screen for new drugs, and monitor the molecular impact of disease treatment.